Yale Pediatric Endocrinology Clinic
New Haven, Connecticut, 06520, United States
NCT Number: NCT02004561
Determine the short and long term safety and efficacy of the Gastric bypass , laparoscopic sleeve gastrectomy, and Gastric banding (LAGB) on severely obese adolescents. The procedure selection is made by the patient or patient and guardian. This is not a randomized trial.
This study is active but is not currently recruiting participants.
Notify Me14 year–19 year
All sexes
Observational
New Haven, Connecticut, 06520, United States
Twenty-six obese adolescents with plans to undergo bariatric surgery for clinical treatment will be recruited for research study during screening process at the Yale Adolescent Bariatric Surgery Clinic. After the appropriate discussion with surgeon, the choice of procedure will be made by subject and legal guardian.
Every bariatric patient must have completed the thorough six-month evaluation period established by the Yale's Adolescent Bariatric Clinic.
This standard of care pre-operative testing provides as a screening tool to ensure every adolescent bariatric patient is mentally and physically appropriate for this surgery.
When a subject is approved for surgery, he or she will meet with Bariatric Surgeon to discuss benefits and risks of each bariatric surgery. After the appropriate discussion with surgeon, the choice of procedure will be made by subject and legal guardian. For research purposes, we seek to monitor the progress of the patients enrolled in Yale's Adolescent Bariatric Surgery Clinic. Collecting pre and post long term operative data will allow us to describe this efficacy and potential complications that arise with RYGB vs LAGB.
As standard of care, all subjects will have undergone pre-operative testing established by Adolescent Bariatric Surgery Clinic before any of the bariatric surgeries.
For research purposes:
During RYGB or LAGB Surgery
Data collection will continue for 24 months post-operatively and include both research testing and standard of care clinical appointments.
Post Surgery 2 week 2 months 3 months 6 months 12 months 24 months Standard Of Care Post-op Post-op Post-op Post-op Post-op Post-op Anthropometric X X X X X X Measures Hemoglobin A1c X X X X X
Anthropometric Measures and HBA1c Anthropometric measures will be done at study enrollment, monthly leading up to the surgery RYGB or LAGB, and 2 weeks, 2 months, 3 months, 6 months, 12 months and 24 months post operatively. These measures include height, weight, BMI, BMI Z score, systolic and diastolic blood pressure, resting heart rate, % fat mass, and total fat mass. Demographic data includes ethnicity and family income. HbA1c will be completed at the 3, 6 , 12, and 24 month post operative time period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Youth 14-19yrs
Exclusion criteria
Time frame: baseline, 2 month, 3 month, 12 month
Glucose tolerance changes measured by 3 hour oral glucose tolerance test.
Time frame: Baseline, 2 weeks, 2 mnths, 3 months, 6 months, 12 months, 24 months
Height, weight, body fat percentage changes
Time frame: Baseline, 2 weeks, 2 mnths, 3 months, 6 months, 12 months, 24 months
Changes in vitamin/mineral blood levels
Time frame: baseline, 2 weeks, 2 months, 3 months, 6 months, 12 months, 24 months
Abdominal MRI
Yale University
Other
Outcomes Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, and Gastric Bypass Surgeries in Obese Adolescents
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06779721
Body Weight, Glucose Metabolism Disorders
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT06967389
Body Weight, Body Weight Changes
Lexington, Kentucky, United States
View Trial DetailsNCT07714759
Body Weight, Metabolic Abnormalities
Gainesville, Florida, United States
View Trial DetailsNCT07593170
Akkermansia Muciniphila, Body Weight
Changsha, Hunan, China
View Trial Details